These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 33420414)

  • 1. METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner.
    Pan X; Hong X; Li S; Meng P; Xiao F
    Exp Mol Med; 2021 Jan; 53(1):91-102. PubMed ID: 33420414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of 7-
    Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y
    Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells.
    Hu D; Li M; Su J; Miao K; Qiu X
    Genet Test Mol Biomarkers; 2019 Mar; 23(3):156-165. PubMed ID: 30807260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3-mediated m
    Zhou Z; Cao Y; Yang Y; Wang S; Chen F
    Epigenetics; 2023 Dec; 18(1):2217033. PubMed ID: 37243702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells.
    Wang Y; Zhao L; Xiao Q; Jiang L; He M; Bai X; Ma M; Jiao X; Wei M
    Gynecol Oncol; 2016 Jun; 141(3):592-601. PubMed ID: 26644266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma.
    Reustle A; Fisel P; Renner O; Büttner F; Winter S; Rausch S; Kruck S; Nies AT; Hennenlotter J; Scharpf M; Fend F; Stenzl A; Bedke J; Schwab M; Schaeffeler E
    Int J Cancer; 2018 Dec; 143(12):3181-3193. PubMed ID: 30070687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome-Derived MicroRNA-221-3p Desensitizes Breast Cancer Cells to Adriamycin by Regulating
    Hong X; Pan X
    Cancer Biother Radiopharm; 2024 Aug; 39(6):463-475. PubMed ID: 38529940
    [No Abstract]   [Full Text] [Related]  

  • 8. A1BG-AS1 promotes adriamycin resistance of breast cancer by recruiting IGF2BP2 to upregulate ABCB1 in an m6A-dependent manner.
    Wang J; Xu J; Zheng J
    Sci Rep; 2023 Nov; 13(1):20730. PubMed ID: 38007504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth.
    Wu S; Wang H; Yang Q; Liu Z; Du J; Wang L; Chen S; Lu Q; Yang DH
    Cancer Lett; 2024 Aug; 597():217058. PubMed ID: 38880226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
    Chang L; Hu Z; Zhou Z; Zhang H
    Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1.
    Pan X; Hong X; Lai J; Cheng L; Cheng Y; Yao M; Wang R; Hu N
    Front Oncol; 2020; 10():441. PubMed ID: 32426266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
    Li S; Lu X; Zheng D; Chen W; Li Y; Li F
    J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.
    He M; Wu H; Jiang Q; Liu Y; Han L; Yan Y; Wei B; Liu F; Deng X; Chen H; Zhao L; Wang M; Wu X; Yao W; Zhao H; Chen J; Wei M
    Mol Oncol; 2019 Feb; 13(2):403-421. PubMed ID: 30536571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-27a-3p Reverses Adriamycin Resistance by Targeting BTG2 and Activating PI3K/Akt Pathway in Breast Cancer Cells.
    Zhu B; Chen W; Fu Y; Cui X; Jin L; Chao J; Yun X; Gao P; Shan S; Li J; Yin X; Zhu C; Qin X
    Onco Targets Ther; 2020; 13():6873-6884. PubMed ID: 32764979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.
    Lin S; Zhu Y; Ji C; Yu W; Zhang C; Tan L; Long M; Luo D; Peng X
    J Clin Endocrinol Metab; 2022 Jan; 107(2):474-490. PubMed ID: 34562008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N
    Huang T; Cao L; Feng N; Xu B; Dong Y; Wang M
    Bioengineered; 2021 Dec; 12(2):10935-10944. PubMed ID: 34866525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
    Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y
    Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydrotestosterone Induces Chemo-Resistance of Triple-Negative Breast MDA-MB-231 Cancer Cells Towards Doxorubicin Independent of ABCG2 and miR-328-3p.
    Al-Momany B; Hammad H; Ahram M
    Curr Mol Pharmacol; 2021; 14(5):860-870. PubMed ID: 34061013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer.
    Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y
    Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of METTL3-mediated m6A modification in depression-induced cognitive deficits.
    Niu J; Wang B; Wang T; Zhou T
    Am J Med Genet B Neuropsychiatr Genet; 2022 Apr; 189(3-4):86-99. PubMed ID: 35591810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.